Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Ellagic Acid and Nitric Oxide

supplement:

Ellagic Acid

Research Papers that Mention the Interaction

Besides, EA significantly improved nitric oxide synthase activity, antioxidant capacity and markers of endothelial dysfunction in plasma.
International journal of cardiology  •  2014  |  View Paper
Our data indicate that ellagic acid exerts its protective effects by inhibiting NADPH oxidase-induced overproduction of superoxide, suppressing the release of NO by down-regulating iNOS, enhancing cellular antioxidant defenses, and attenuating oxLDL-induced LOX-1 up-regulation and eNOS down-regulation.
Journal of vascular surgery  •  2010  |  View Paper
Results showed that EA dose dependently provoked antidepressant-like effects and also decreased the hippocampal NO level as well as expression of NMDA-Rs.
Neuropeptides  •  2019  |  View Paper
Elevated levels of malondialdehyde (MDA) and nitric oxide (NO) in renal and hepatic tissue was reduced by EA treatment (all p<0.001).
Pharmacological reports : PR  •  2018  |  View Paper
In conclusion, ellagic acid attenuates hypertension, possibly improving nitric oxide bioavailability.
Planta medica  •  2017  |  View Paper
The present study discloses that EA suppresses HO‐1 and, its renoprotection is also linked to its anti‐inflammatory and antiapoptotic properties, as well as the reduction of nitric oxide and endothelin‐1.
Journal of biochemical and molecular toxicology  •  2014  |  View Paper
However, MDA, TOS, OSI, and NO levels were found to be significantly reduced in the ellagic acid-treated diabetic group compared to the untreated diabetic group in these tissues (for both parameters, p < 0.05).
Neurological Sciences  •  2011  |  View Paper
Administration of EA and/or PSO decreased the intestinal damage, PGE2, MDA and NO levels and MPO, XO and AD activities and increased GSH level.
Indian journal of biochemistry & biophysics  •  2011  |  View Paper
EA significantly improved the status of antioxidants and decreased TBARS, hydroperoxides, NO , PCC and liver marker enzymes at the dose of 60 mg/kg body weight when compared with the alcohol-treated group.
Singapore medical journal  •  2007  |  View Paper
EA exposure alleviated the developmental malformations observed in treated embryos and decreased the levels of SA and NO in those same embryos.
Journal of biochemical and molecular toxicology  •  2006  |  View Paper
Show More